Rischin, D.; Migden, M. R.; Chang, A. L. S.; al., E. Primary Analysis of Phase 2 Results for Cemiplimab, a Human Monoclonal Anti-PD-1, in Patients With Metastatic Cutaneous Squamous Cell Carcinoma. J of Skin 2018, 2, S79.